Overview
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
Biointron holds a leading position in the antibody expression service industry. From gene sequence to purified antibodies, our production only takes 2 weeks. We have delivered tens of thousands of recombinant antibodies for more than 1,500 biotech and pharma companies worldwide.
Company News
Biointron’s Q3 2024 Antibody Industry Report is OUT NOW!
Oct 17, 2024
Posted by Biointron Biological